课题基金 / 基金详情

Regulation of Enteric Virus Secretory Diarrhea

Regulation of Enteric Virus Secretory Diarrhea
肠道病毒分泌性腹泻的调节
批准号:
9316119
负责人:
Joseph M. Hyser
金额:
$7.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-15 至 2019-03-31

项目摘要

项目成果

Joseph M. Hyser的其他基金

相似基金

相关文献

中文摘要
翻译
腹泻是全世界主要的死亡和疾病原因,导致5.6亿人死亡 5岁以下儿童。轮状病毒(RV)引起约70%的病毒性腹泻,甚至在两种疫苗中也是如此 每年杀死21.5万名儿童。轮状病毒腹泻主要是由于过量的氯离子分泌导致液体丢失,但 负责轮状病毒诱导的体液分泌的细胞通路没有明确的定义,这限制了发展的努力 以及测试潜在的止泻药物,当疫苗保护儿童时,这些药物可用于治疗 还不够。氯(Cl-)分泌通道的激活受细胞内钙(Ca~(2+))和循环 核苷酸(CAMP)信号转而激活钙激活的氯离子通道(CACC),如 Anoctamin(ANO)家族,以及cAMP激活的氯离子通道(cAMP-CC),如囊性纤维化 跨膜调节剂(CFTR)。RV腹泻是由于钙离子升高导致的氯离子分泌的经典例子 因为轮状病毒感染的一个标志是钙信号增加,这是由轮状病毒非结构性诱导的 蛋白4(NSP4)。ANO通道是肠道中最突出的钙通道;然而,氯通道负责 轮状病毒腹泻尚未确定。此外,nsp4被认为是轮状病毒诱导的钙离子的主要起始者。 信号;然而,NSP4衍生的信号导致氯通道激活和流体的机制 分泌物还没有得到充分的研究。在目标1中,我们将确定与RV有关的氯离子通道 使用体外和体内两种方法治疗腹泻。关于不同的氯离子的表达,我们知之甚少。 在整个人体肠道,特别是儿童的肠道,我们将使用人类肠道类(HIEs)来 确定关键的氯离子通道及其调节蛋白的基因表达。接下来,我们将测量 利用荧光猝灭试验激活单个氯通道的能力,并确定 这些通道有助于液体分泌使用肠样肿胀分析(ESA)在存在特定的 CL通道阻滞剂。最后,我们将确定Ano1或CFTR的抑制剂是否可以缓解腹泻,以及是否 因此,肠道特异性地删除这些通道是否也能减少腹泻。在目标2中,我们将确定 RV NSP4是否通过激活感受器基质相互作用分子来激活钙离子和cAMP 1(STIM1)。STIM1的激活可以通过存储操作的钙离子进入(SOCE)产生钙信号 以及通过存储操作的cAMP信号通路(SocAMPs)传递cAMP信号。我们会 使用肠道细胞系和表达荧光钙离子和cAMP生物传感器的HIE的活细胞成像来 确定RV和NSP4是否同时激活SOCE和SocAMP,并使用ESA确定 NSP4产生的钙/cAMP信号引起体液分泌。最后,我们将确定阻滞剂是否 SOCE或SocAMPs在体内可减轻RV腹泻。我们的结果将产生对 病毒性腹泻的机制和可应用于未来研究的新型生物传感器HIE模型系统 肠道病毒,如诺如病毒和星状病毒。
英文摘要
Diarrheal is a leading cause of death and illness throughout the world and causes 560 million deaths of children under 5 years old. Rotavirus (RV) causes about 70% of viral diarrheas and even with two vaccines kills 215,000 children yearly. RV diarrhea is mainly due to excess Cl- secretion that drives fluid loss, but the cellular pathways responsible for RV-induced fluid secretion are not well defined, which limits efforts to develop and testing of potential anti-diarrheal drugs that can be used to treat children when protection by vaccines is insufficient. Activation of chloride (Cl-) secretory channels is regulated by intracellular calcium (Ca2+) and cyclic nucleotide (cAMP) signals These signals in turn activate Ca2+-activated Cl- channels (CaCC), such as anoctamin (Ano) family, and cAMP-activated Cl- channels (cAMP-CC), such as the cystic fibrosis transmembrane regulator (CFTR). RV diarrhea is the classic example of Cl- secretion due to elevated Ca2+ because a hallmark of RV infection is increased Ca2+ signaling, which is induced by the RV nonstructural protein 4 (NSP4). Ano channels are the prominent CaCCs in the gut; however, the Cl- channels responsible for RV diarrhea have yet to be identified. Additionally, NSP4 is considered the primary initiator of RV-induced Ca2+ signals; however, the mechanisms by which NSP4-derived signals cause Cl- channel activation and fluid secretion have not been adequately explored. In Aim 1, we will identify the Cl- channels responsible for RV diarrhea using both in vitro and in vivo approaches. Little is known about the expression of different Cl- channels throughout the human intestine, particularly children, we will use human intestinal enteroids (HIEs) to determine gene expression of the key Cl- channels and their regulatory proteins. Next, we will measure the ability of RV to activate individual Cl- channels using a fluorescence quench assay and determine whether those channels contribute to fluid secretion using the enteroid swelling assay (ESA) in the presence of specific Cl- channel blockers. Lastly, we will determine whether inhibitors of Ano1 or CFTR will attenuate diarrhea and if so whether intestinal specific deletion of those channels also reduces diarrhea. In Aim 2, we will determine whether RV NSP4 activates both Ca2+ and cAMP through activation of the sensor stromal interacting molecule 1 (STIM1). STIM1 activation can generate Ca2+ signals through the store-operated Ca2+ entry (SOCE) pathway, as well as cAMP signals through the store-operated cAMP signaling (SOcAMPs) pathway. We will use live cell imaging of intestinal cell lines and HIEs expressing fluorescent Ca2+ and cAMP biosensors to determine whether RV and NSP4 activate both SOCE and SOcAMPs and use the ESA to determine whether the Ca2+/cAMP signals generated by NSP4 cause fluid secretion. Lastly, we will determine whether blockers of SOCE or SOcAMPs will attenuate RV diarrhea in vivo. Our results will generate critical insights into the mechanisms of viral diarrhea and new biosensor HIE model systems that can be applied to future studies enteric virus, such as noroviruses and astroviruses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enteric Virus Exploitation of Store-operated and Purinergic Calcium Signaling
  • 批准号:
    10176473
  • 项目类别:
  • 资助金额:
    $35.58万
  • 财政年份:
    2018
  • 负责人:
    Joseph M. Hyser
  • 依托单位:
Enteric virus exploitation of calcium signaling
  • 批准号:
    10735222
  • 项目类别:
  • 资助金额:
    $64.41万
  • 财政年份:
    2018
  • 负责人:
    Joseph M. Hyser
  • 依托单位:
Enteric Virus Exploitation of Store-operated and Purinergic Calcium Signaling
  • 批准号:
    10437691
  • 项目类别:
  • 资助金额:
    $35.58万
  • 财政年份:
    2018
  • 负责人:
    Joseph M. Hyser
  • 依托单位:
Enteric Virus Calcium Channel Inhibitors
  • 批准号:
    8543722
  • 项目类别:
  • 资助金额:
    $12.29万
  • 财政年份:
    2012
  • 负责人:
    Joseph M. Hyser
  • 依托单位:
海外基金